# Evaluation of the CONVIVO System

> **NCT05139277** · NA · RECRUITING · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Glioblastoma
- Glial Tumor
- Brain Metastases
- Meningioma
- Schwannoma
- Pituitary Tumor

## Interventions

- **DIAGNOSTIC_TEST:** CONVIVO system
- **OTHER:** Conventional histologic evaluation

## Key facts

- **NCT ID:** NCT05139277
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-28
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05139277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05139277, "Evaluation of the CONVIVO System". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05139277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*